The effect of squamous and/or glandular differentiation on recurrence, progression and survival in urothelial carcinoma of bladder
- First Online:
- 121 Downloads
The effects of squamous and/or glandular differentiation in urothelial carcinoma of bladder on recurrence, progression and survival rate were evaluated in this study.
Patients and methods
Between 1998 and 2003, a total of 223 patients who had been treated with transurethral resection for bladder cancers were evaluated. The patients were divided into two groups as; Group I: tumor patients with squamous and/or glandular differentiation, Group II: patients without these findings.
Histologically 189 (84.7%) were conventional urothelial carcinoma and 34 (15.2%) were tumors with squamous and/or glandular differentiation. The mean age of the patients was 64.4 ± 12.7 (range 36–81) years. Survival rates within a period of 46.23 ± 14.8 (12–67) months were 76.47% for Group I and 89.94% for Group II (P = 0.027). The stage distribution as pTa, pT1, and ≥pT2 was 2 (5.9%), 18 (52.9%), and 14 (41.2%) in Group I and 101 (53.4%), 51 (27%) and 37 (19.6%) in group II, respectively (P = 0.001). There was a statistically significant tendency towards higher stage at presentation in Group I and the grade distribution was significantly higher in Group I than Group II (P < 0.001).
High recurrence rates and poor prognosis of these patients should be kept in mind in the follow-up period. In this respect, these patients should be followed up closely.
KeywordsBladder Carcinoma Squamous Glandular Prognosis
- 6.International Union Against Cancer (1997) TNM. Classification of malignant tumours, 5th edn. Wiley-Liss, New York, pp 187–190Google Scholar
- 7.Mostofi FK, Sobin LH, Torlini H (1973) Histologic typing of urinary bladder tumours. World Health Organization, Geneva, pp 1–20Google Scholar
- 8.Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) World Health Organization classification of tumors. Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, pp 90–99Google Scholar
- 9.Ayala AG, Ro JY (1989) Premalignant lesions of the urothelium and transitional cell tumors. In: Young RH (ed) Pathology of the urinary bladder. Churchill Livingstone, New York, NY, pp 65–101Google Scholar
- 11.Young RH (2001) Pathology of carcinomas of the urinary bladder. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS (eds) Comprehensive textbook of genitourinary oncology, 2nd edn. LippincottWilliams ( Wilkins, pp 310–321Google Scholar
- 12.Pugh RCB (1959) The pathology of bladder tumours. In: Wallace DW (ed) Tumours of the bladder, vol. II. In: Smithers DW (ed) Neoplastic disease at various sites. London: E ( S LivingstoneGoogle Scholar
- 18.Logothesis CJ, Dexeus FH, Chong C (1989) Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors. The MD Anderson experience. J Urol 141:33–37Google Scholar